NCT03661866Active, not recruiting
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- No phase declared
- Sponsor
- Target PharmaSolutions, Inc.
- Participants (registry)
- 15000
- Start
- December 2018
- Primary completion
- December 2050 (planned)
- Study completion
- December 2050 (planned)
- Last registry update
- March 2026
- Countries
- United States, Canada, Germany, Spain
Conditions studied: Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.